1. Home
  2. GNPX vs IZM Comparison

GNPX vs IZM Comparison

Compare GNPX & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

N/A

Current Price

$1.68

Market Cap

2.2M

Sector

Health Care

ML Signal

N/A

Logo ICZOOM Group Inc.

IZM

ICZOOM Group Inc.

N/A

Current Price

$0.89

Market Cap

2.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
GNPX
IZM
Founded
2009
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Video Chains
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.3M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
GNPX
IZM
Price
$1.68
$0.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 110.6K
42.9K
Earning Date
11-13-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$10.39
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$0.21
52 Week High
$9.99
$2.73

Technical Indicators

Market Signals
Indicator
GNPX
IZM
Relative Strength Index (RSI) 31.86 57.40
Support Level $0.80 $0.27
Resistance Level $2.42 $0.88
Average True Range (ATR) 0.19 0.08
MACD -0.01 0.03
Stochastic Oscillator 2.80 54.31

Price Performance

Historical Comparison
GNPX
IZM

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

About IZM ICZOOM Group Inc.

ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.

Share on Social Networks: